| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 1, 24 | Israel Biotech Fund II, L.P. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund GP Partners, L.P. | Exercise | - | |
| Mar 1, 24 | I.B.F. Management Ltd. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund GP Partners II, L.P. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund I, L.P. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund II, L.P. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund GP Partners, L.P. | Exercise | - | |
| Mar 1, 24 | I.B.F. Management Ltd. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund GP Partners II, L.P. | Exercise | - | |
| Mar 1, 24 | Israel Biotech Fund I, L.P. | Exercise | - |
Advaxis, Inc. (ADXS) has recorded 932 insider transactions from 35 insiders. Total insider buying volume stands at $121.2M, while total selling volume is $42.5M. Overall insider sentiment is bullish (71% purchases).
Advaxis, Inc. (ADXS) has recorded 932 insider operations, including 152 open-market purchases ($121.2M), 62 sales ($42.5M) and 718 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (71% purchases).
Advaxis, Inc. shows moderate insider activity with 5 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are O'Connor Daniel (CEO), MOORE THOMAS A (CEO) & LOMBARDO ANTHONY A (CEO), with respectively 137, 33, 16 transactions.
Across all 932 recorded transactions, the breakdown by type is: grant (417, 45%), tax (179, 19%), buys (152, 16%), exercise (99, 11%), sales (62, 7%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advaxis, Inc. has recorded 932 insider operations in total, including 152 open-market purchases ($121.2M), 62 sales ($42.5M) and 718 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on March 1, 2024.
Insiders at Advaxis, Inc. are currently net buyers, with 71% purchases and 29% sales across all reported transactions. Total buy volume is $121.2M versus $42.5M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 35 insiders at Advaxis, Inc. (ADXS). O'Connor Daniel (CEO, 137 tx), MOORE THOMAS A (CEO, 33 tx), LOMBARDO ANTHONY A (CEO, 16 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for ADXS is bullish, based on a 71% buy ratio across 214 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Advaxis, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.